From Wikipedia, the free encyclopedia
Chemical compound
NEFA
|
|
(4aR,9aS)-N-Ethyl-4,4a,9,9a-tetrahydro-1H-fluoren-4a-amine
|
CAS Number | |
---|
PubChem
CID | |
---|
UNII | |
---|
|
Formula | C15H19N |
---|
Molar mass | 213.324 g·mol−1 |
---|
3D model (
JSmol) | |
---|
CCN[C@]12CC=CC[C@H]1CC3=CC=CC=C23
|
InChI=1S/C15H19N/c1-2-16-15-10-6-5-8-13(15)11-12-7-3-4-9-14(12)15/h3-7,9,13,16H,2,8,10-11H2,1H3/t13-,15+/m0/s1 Key:DRCWOKJLSQUJPZ-DZGCQCFKSA-N
|
(verify) |
NEFA is a moderate affinity
NMDA antagonist (IC50 = 0.51 μM). It is a structural analog of
phencyclidine.
[1] It was first
synthesized by a team at
Parke-Davis in the late 1950s.
[2]
References
|
---|
Psychedelics (
5-HT2A agonists) |
Benzofurans | |
---|
Lyserg‐ amides | |
---|
Phenethyl‐ amines |
2C-x |
25x-NBx | 25x-
NB | |
---|
25x-
NB3OMe | |
---|
25x-
NB4OMe | |
---|
25x-
NBF | |
---|
25x-
NBMD | |
---|
25x-
NBOH | |
---|
25x-
NBOMe | |
---|
Atypical structures | |
---|
|
---|
25x-NMx | |
---|
N-(2C)-fentanyl | |
---|
|
---|
3C-x | |
---|
4C-x | |
---|
DOx | |
---|
HOT-x | |
---|
MDxx | |
---|
Mescaline (subst.) | |
---|
TMAs |
- TMA
- TMA-2
- TMA-3
- TMA-4
- TMA-5
- TMA-6
|
---|
Others | |
---|
|
---|
Piperazines | |
---|
Tryptamines |
alpha-alkyltryptamines | |
---|
x-
DALT | |
---|
x-
DET | |
---|
x-
DiPT | |
---|
x-
DMT |
-
4,5-DHP-DMT
-
2,N,N-TMT
-
4-AcO-DMT
-
4-HO-5-MeO-DMT
-
4,N,N-TMT
-
4-Propionyloxy-DMT
-
5,6-diBr-DMT
-
5-AcO-DMT
-
5-Bromo-DMT
-
5-MeO-2,N,N-TMT
-
5-MeO-4,N,N-TMT
-
5-MeO-α,N,N-TMT
-
5-MeO-DMT
-
5-N,N-TMT
-
7,N,N-TMT
-
α,N,N-TMT
-
(Bufotenin) 5-HO-DMT
-
DMT
-
Norbaeocystin
-
(Psilocin) 4-HO-DMT
-
(Psilocybin) 4-PO-DMT
|
---|
x-
DPT | |
---|
Ibogaine-related | |
---|
x-
MET | |
---|
x-
MiPT | |
---|
Others | |
---|
|
---|
Others | |
---|
|
---|
Dissociatives (
NMDAR
antagonists) | |
---|
Deliriants (
mAChR
antagonists) | |
---|
Others | |
---|
|
---|
AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor | |
---|
KARTooltip Kainate receptor | |
---|
NMDARTooltip N-Methyl-D-aspartate receptor | |
---|
|